Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-GEOD-4600

ABSTRACT: Transcription profiling by array of human SH-SY5Y cells transfected with an MeCP2 transcriptional repressor

OTHER RELATED OMICS DATASETS IN: PRJNA94391

PROVIDER: E-GEOD-4600 | ExpressionAtlas | 2025-01-24

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-GEOD-4600-analysis-methods.tsv	Tabular
	E-GEOD-4600-atlasExperimentSummary.Rdata	Rdata
	E-GEOD-4600-configuration.xml	Xml
	E-GEOD-4600-percentile-ranks.tsv	Tabular
	E-GEOD-4600.condensed-sdrf.tsv	Tabular

Items per page:

1 - 5 of 85

Similar Datasets

E-MTAB-1131

Project description:Transcription profiling by array of human MEC2 cells transfected with miR-125b

2025-01-23 | E-MTAB-1131 | ExpressionAtlas

E-MTAB-108

Project description:Transcription profiling by array of human LNCaP cells transfected with GFP-FOXP3 cDNA

2025-01-23 | E-MTAB-108 | ExpressionAtlas

E-GEOD-10821

Project description:Transcription profiling by array of human LMP1 transfected CD10-positive germinal center B cells

2025-01-16 | E-GEOD-10821 | ExpressionAtlas

E-MEXP-1913

Project description:Transcription profiling of human neuroblastoma cell line SH-SY5Y transfected to produce phenotypes with low, medium or high levels of beta-amyloid peptides with 40 or 42 amino acids

2025-01-22 | E-MEXP-1913 | ExpressionAtlas

E-MEXP-2160

Project description:Transcription profiling by array of human myometrial cells transfected by NFKB (p65) and CEBP alone and in combination.

2025-01-22 | E-MEXP-2160 | ExpressionAtlas

Profiling wt SOD versus ALS SOD1(G93A) mutant

Project description:Whole-genome profiling of SH-SY5Y cells was done on neuroblastoma SH-SY5Y stably transfected with cDNAs coding for SOD1WT or the mutant SOD1(G93A) protein.

2010-12-22 | GSE21298 | GEO

Transcription profiling of human differentiated vs. undifferentiated SH-SY5Y cells transfected with a MeCP2 (transcriptional repressor) decoy to investigate the neurodevelopmental disorder Rett syndrome

Project description:Rett syndrome (RTT) is an X-linked dominant neurodevelopmental disorder caused by mutations in MECP2, encoding methyl-CpG-binding protein 2. MeCP2 is a transcriptional repressor elevated in mature neurons and is predicted to be required for neuronal maturation by regulating multiple target genes. Identifying primary gene targets in either Mecp2-deficient mice or human RTT brain has proven to be difficult, perhaps because of the transient requirement for MeCP2 during neuronal maturation. In order to experimentally control the timing of MeCP2 expression and deficiency during neuronal maturation, human SH-SY5Y cells undergoing mature neuronal differentiation were transfected with methylated MeCP2 oligonucleotide decoy to disrupt the binding of MeCP2 to endogenous targets. Genome-wide expression microarray analysis identified all four known members of the inhibitors of differentiation or inhibitors of DNA-binding (ID1, ID2, ID3 and ID4) subfamily of helix-loop-helix genes as novel neuronal targets of MeCP2. Chromatin immunoprecipitation analysis confirmed binding of MeCP2 near or within the promoters of ID1, ID2 and ID3, and quantitative RT-PCR confirmed increased expression of all four Id genes in Mecp2-deficient mouse brain. All four ID proteins were significantly increased in Mecp2-deficient mouse and human RTT brain using immunofluorescence and laser scanning cytometric analyses. Because of their involvement in cell differentiation and neural development, ID genes are ideal primary targets for MeCP2 regulation of neuronal maturation that may explain the molecular pathogenesis of RTT.

2007-10-26 | E-GEOD-4600 | biostudies-arrayexpress

E-MTAB-2277

Project description:RNA-seq of coding RNA in human SH-SY5Y cells with shRNA knockdown of RNA-binding protein Unkempt (Unk)

2025-01-23 | E-MTAB-2277 | ExpressionAtlas

Identifying targets of MeCP2 during neuronal maturational differentiation

Project description:Rett syndrome (RTT) is an X-linked dominant neurodevelopmental disorder caused by mutations in MECP2, encoding methyl-CpG binding protein 2. MeCP2 is a transcriptional repressor elevated in mature neurons and is predicted to be required for neuronal maturation by regulating multiple target genes. Identifying primary gene targets in either Mecp2-deficient mice or human RTT brain has proven to be difficult, perhaps because of the transient requirement for MeCP2 during neuronal maturation. In order to experimentally control the timing of MeCP2 expression and deficiency during neuronal maturation, human SH-SY5Y cells undergoing mature neuronal differentiation were transfected with methylated MeCP2 oligonucleotide decoy to disrupt the binding of MeCP2 to endogenous targets. Genome-wide expression microarray analysis identified all four known members of the inhibitors of differentiation or inhibitors of DNA binding (ID1, ID2, ID3 and ID4) subfamily of helix-loop-helix (HLH) genes as novel neuronal targets of MeCP2. Chromatin immunoprecipitation analysis confirmed binding of MeCP2 near or within the promoters of ID1, ID2 and ID3, and quantitative RT-PCR confirmed increased expression of all four Id genes in Mecp2-deficient mouse brain. All four ID proteins were significantly increased in Mecp2-deficient mouse and human RTT brain using immunofluorescence and laser scanning cytometric analyses. Because of their involvement in cell differentiation and neural development, ID genes are ideal primary targets for MeCP2 regulation of neuronal maturation that may explain the molecular pathogenesis of RTT. Keywords: Neuronal Differentiation, Targets of MeCP2, Rett syndrome.

2006-06-15 | GSE4600 | GEO

E-MTAB-1160

Project description:Transcription profiling by array of HaCaT cells transfected with HPV11 HPV16 or HPV45 genome

2025-01-23 | E-MTAB-1160 | ExpressionAtlas